Company Epsilon Healthcare Limited Other OTC
Equities
HDRPF
AU0000137598
Pharmaceuticals
Business Summary
Sales per Business
AUD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Medicinal Cannabis
59.8
%
| 3 | 48.5 % | 4 | 59.8 % | +59.45% |
Hydroponics Equipment, Materials and Nutrients
40.2
%
| 3 | 51.5 % | 3 | 40.2 % | +1.03% |
Sales per region
AUD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Australia
59.8
%
| 3 | 48.5 % | 4 | 59.8 % | +59.45% |
Canada
40.2
%
| 3 | 51.5 % | 3 | 40.2 % | +1.03% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Daniel Sanghera
CEO | Chief Executive Officer | - | 11-20 |
Lin Li
AUD | Comptroller/Controller/Auditor | - | - |
Marcelo Mora
SEC | Corporate Secretary | 60 | 22/12/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Alan Beasley
CHM | Chairman | - | 28/08/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 300,354,011 | 181,387,905 ( 60.39 %) | 0 | 60.39 % |
Company contact information
Epsilon Healthcare Ltd.
9 Castlereagh Street Level 17
2000, Sydney
+
http://www.epsilonhealthcare.com.au![address Epsilon Healthcare Limited(HDRPF)](https://cdn.zonebourse.com/static/address/41647550.png)
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+51.99% | 803B | |
-5.72% | 351B | |
+18.94% | 324B | |
+11.07% | 303B | |
+16.96% | 243B | |
+2.25% | 228B | |
+11.15% | 217B | |
+7.59% | 164B | |
-3.65% | 155B |